ACIST Medical Systems
Michael Hicks, RCIS, CCVT, FACVP, has extensive experience in the cardiovascular field, currently serving as the National Clinical Field Trainer at ACIST Medical Systems since February 2014. This role follows progressive responsibilities as a Senior Clinical Specialist and Clinical Specialist in the St. Louis Region, where duties include providing procedural support to interventional cardiologists, identifying training needs, and fostering adoption of ACIST products through consultative strategies. Prior experience includes serving as a Clinical Sales Specialist at ev3 and a Clinical Support Specialist at Covidien, where technical and clinical support during endovascular procedures was provided. Earlier roles at West County Heart Alliance, Barnes-Jewish Hospital, and St. Louis University Hospital focused on invasive cardiovascular procedures, including scrubbing and assisting with diagnostic and interventional caths. Michael holds a Certificate in Cardiovascular Technology and is a Registered Cardiovascular Invasive Specialist.
This person is not in any teams
This person is not in any offices
ACIST Medical Systems
1 followers
ACIST Medical Systems, Inc. is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. It is also a global market leader in advanced contrast imaging systems for cardiovascular angiography and radiology imaging. Through these products, ACIST is demonstrating its commitment to bringing unique and innovative technologies that simplify cardiovascular procedures and empower clinicians to treat patients with superior care. As part of the Bracco Group, ACIST benefits from the resources of a multinational conglomerate with broad expertise in cath lab technology and a dedication to continuous advancement. Headquartered in Eden Prairie, Minnesota, USA, ACIST has worldwide presence with over 300 direct employees and facilities in Silicon Valley, Maastricht, Shanghai and Tokyo.